Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP488454.RAx33G905JCjWhG9aQ5a5i7dIxveXG-yPocWPwOy2VJS0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP488454.RAx33G905JCjWhG9aQ5a5i7dIxveXG-yPocWPwOy2VJS0130_assertion type Assertion NP488454.RAx33G905JCjWhG9aQ5a5i7dIxveXG-yPocWPwOy2VJS0130_head.
- NP488454.RAx33G905JCjWhG9aQ5a5i7dIxveXG-yPocWPwOy2VJS0130_assertion description "[We also demonstrated comprehensively that FLJ10540 and osteopontin were not only overexpressed in NPC specimens, but also significantly correlated with advanced tumor and lymph node-metastasis stages, and had a poor 5-year survival rate, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP488454.RAx33G905JCjWhG9aQ5a5i7dIxveXG-yPocWPwOy2VJS0130_provenance.
- NP488454.RAx33G905JCjWhG9aQ5a5i7dIxveXG-yPocWPwOy2VJS0130_assertion evidence source_evidence_literature NP488454.RAx33G905JCjWhG9aQ5a5i7dIxveXG-yPocWPwOy2VJS0130_provenance.
- NP488454.RAx33G905JCjWhG9aQ5a5i7dIxveXG-yPocWPwOy2VJS0130_assertion SIO_000772 22591637 NP488454.RAx33G905JCjWhG9aQ5a5i7dIxveXG-yPocWPwOy2VJS0130_provenance.
- NP488454.RAx33G905JCjWhG9aQ5a5i7dIxveXG-yPocWPwOy2VJS0130_assertion wasDerivedFrom befree-20140225 NP488454.RAx33G905JCjWhG9aQ5a5i7dIxveXG-yPocWPwOy2VJS0130_provenance.
- NP488454.RAx33G905JCjWhG9aQ5a5i7dIxveXG-yPocWPwOy2VJS0130_assertion wasGeneratedBy ECO_0000203 NP488454.RAx33G905JCjWhG9aQ5a5i7dIxveXG-yPocWPwOy2VJS0130_provenance.